Professor Masakazu Haneda is Professor Emeritus and Visiting Professor at the Asahikawa Medical University, and Director of the AMC Nishi-Umeda Clinic in Osaka, Japan.
Professor Haneda is the Chief Secretary for the Japanese Society of Diabetic Complications and a council member of bodies including the Japan Diabetes Society, the Japan Endocrine Society, the Japanese Society of Internal Medicine and the Japanese Society of Nephrology. Other professional affiliations include the American Diabetes Association, the American Society of Nephrology, the International Society of Nephrology and the European Association for the Study of Diabetes.
Professor Haneda’s research interests have focused on the pathophysiology of diabetic nephropathy and its management, and the efficacy and safety of glucose-lowering agents in the Japanese population. He has been involved in clinical trials for a number of new therapies, including angiotensin receptor blockers, SGLT2 inhibitors and DPP-4 inhibitors.
Professor Haneda has authored or co-authored over 350 publications in peer-reviewed journals. In 1995 and 2013, he received the Japanese Diabetes Society prizes, as well as the Hokkaido Medical Association Award in 2010 and the Expert Investigator Award from the Japan Society of Diabetic Complications in 2014.